comparemela.com
Home
Live Updates
NeuroSense Therapeutics : Receives FDA Clearance of IND for PrimeC for the Treatment of ALS - Form 6-K : comparemela.com
NeuroSense Therapeutics : Receives FDA Clearance of IND for PrimeC for the Treatment of ALS - Form 6-K
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
- PrimeC, a novel combination therapy, demonstrated efficacy and safety in Phase IIa... | March 21, 2022
Related Keywords
Boston ,
Massachusetts ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
,
Linkedin ,
Twitter ,
European Medicines Agency ,
Prnewswire Neurosense Therapeutics Ltd ,
Drug Administration ,
Nasdaq ,
Neurosense Therapeutics Ltd ,
Neurosense Therapeutics Receives ,
Sense Therapeutics ,
Orphan Drug Designation ,
Massachusetts General Hospital ,
Neuron Derived Exosomes ,
Neurosense Therapeutics Ltd Stock Exchange ,
News ,
Information ,
Press Release ,
Neurosense ,
Herapeutics ,
Eceives ,
Fda ,
Clearance ,
F ,
End ,
Or ,
Zrimec ,
The ,
Treatment ,
Novel ,
Combination ,
Remonstrated ,
Efficacy ,
Safety ,
N ,
Hase Nrsn Il0011809592 ,
comparemela.com © 2020. All Rights Reserved.